|
KMID : 1225720230150020145
|
|
Allergy, Asthma & Immunology Research : AAIR
2023 Volume.15 No. 2 p.145 ~ p.159
|
|
|
KAAACI Allergic Rhinitis Guidelines: Part 2. Update in Non-pharmacological Management
|
|
Park Do-Yang
Lee Yong-Ju
Kim Dong-Kyu
Kim Soo-Whan
Yang Hyeon-Jong
Kim Do-Hyun
Jun Young-Joon
Park Sang-Chul
Kim Bong-Seong
Yang Song-I
Lee Il-Hwan
Kim Min-Ji
Ryu Gwang-Hui
Kang Sung-Yoon
Kim Mi-Ae
Lee Sang-Min
Kim Hyun-Jung
Choi Gil-Soon
Chung Soo-Jie
Lee Hyun-Jong
Kim Hyo-Bin
Choi Jeong-Hee
|
|
|
Abstract
|
|
|
|
Allergic rhinitis is the most common chronic disease worldwide. Various upper airway symptoms lower quality of life, and due to the recurrent symptoms, multiple treatments are usually attempted rather than one definitive treatment. There are alternatives to medical (medication-based) and non-medical treatments. A guideline is needed to understand allergic rhinitis and develop an appropriate treatment plan. We have developed guidelines for medical treatment based on previous reports. The current guidelines herein are associated with the “KAAACI Evidence-Based Guidelines for Allergic Rhinitis in Korea, Part 1: Update in pharmacotherapy” in which we aimed to provide evidence-based recommendations for the medical treatment of allergic rhinitis. Part 2 focuses on non-pharmacological management, including allergen-specific immunotherapy, subcutaneous or sublingual immunotherapy, nasal saline irrigation, environmental management strategies, companion animal management, and nasal turbinate surgery. The evidence to support the treatment efficacy, safety, and selection has been systematically reviewed. However, larger controlled studies are needed to elevate the level of evidence to select rational non-medical therapeutic options for patients with allergic rhinitis.
|
|
|
KEYWORD
|
|
|
Rhinitis, allergic, guideline, surgery, immunotherapy, safety
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|
|